
DNA methylation markers to predict treatment success of biologicals in Crohnโs disease, psoriasis and RheumatoidArthritis. @HorizonEU project GA No. 101095449
Amsterdam
Joined February 2023
- Tweets64
- Following473
- Followers70
- Likes459
If you participate in the Episora Trial what does is exactly mean for patients?
#MethylomicMatters #METHYLOMIC #EpisoraTrial #RheumatoidArthritis #PersonalisedMedicine #PrecisionMedicine #Rheumatology
๐ฌ Have questions about the OmiCrohn study?
Weโve collected the most frequently asked questions about the OmiCrohn study in one easy-to-read FAQ.
๐ Read the FAQ and learn more about the OmiCrohn study: methylomic.eu/wp-content/uplโฆ
#OmiCrohn #METHYLOMIC #CrohnsDisease #IBD
Testimonial Patrick: "When I was given the opportunity to participate in OmiCrohn, I was immediately interested"
methylomic.eu/patient-informโฆ
When the Dutch Sem (28) was diagnosed with Crohnโs disease. Desperate for a solution, Sem requested a second opinion at Amsterdam UMC in 2025. She was immediately given the opportunity to take part in the OmiCrohn study. โIโm doing so well now!โ
methylomic.eu/patient-informโฆ
๐๏ธ Can methylation help us understand why patients respond differently to the same treatments and ultimately help clinicians choose the right treatment for the right patient?
#METHYLOMIC #PersonalisedMedicine #CrohnsDisease #RheumatoidArthritis #Psoriasis #Methylation
We are pleased to announce the next METHYLOMIC workshop: โDNA Methylation for IBD Precision Medicineโ, taking place during UEG Week 2026 in Barcelona, Spain.
๐
19 October 2026
๐ 13:00โ14:00
๐ Room 8.34 | UEG Week, Barcelona
#METHYLOMIC #UEGWeek2026 #IBD #PrecisionMedicine
๐ฌ ๐ฆ๐ฒ๐ฐ๐ผ๐ป๐ฑ ๐ ๐๐ง๐๐ฌ๐๐ข๐ ๐๐ ๐ฑ๐ผ๐ฐ๐๐บ๐ฒ๐ป๐๐ฎ๐ฟ๐ ๐ป๐ผ๐ ๐ฎ๐๐ฎ๐ถ๐น๐ฎ๐ฏ๐น๐ฒ ๐๐ถ๐๐ต ๐๐๐ฏ๐๐ถ๐๐น๐ฒ๐ ๐ถ๐ป ๐๐ถ๐
๐น๐ฎ๐ป๐ดuages
๐ Watch it now and choose your subtitles: youtube.com/watch?v=5myHGw2Wโฆ
#IBD #CrohnsDisease #UlcerativeColitis #METHYLOMIC
๐ฌ The film about the METHYLOMIC project '๐ง๐ต๐ฒ ๐ฆ๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ณ๐ผ๐ฟ ๐๐ฒ๐๐๐ฒ๐ฟ ๐๐ถ๐ผ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐ฟ๐ ๐ถ๐ป ๐๐๐' is now available with English, Dutch, French, Hungarian, Italian, and Slovenian subtitles.
๐ Watch it now and choose your subtitles: buff.ly/8Stjhl1
On the METHYLOMIC project website, you will find a number of new pages about how you can participate in the OmiCrohn study.
At the bottom of this page, you will find links to the various new pages: methylomic.eu/patient-informโฆ
#OmiCrohn #METHYLOMIC
Inside the OmiCrohn Study >>Documentary: Epigenetics and the future of IBD care.
This video offers an introduction to the OMICROHN Study, developed within the Horizon Europe project METHYLOMIC.
youtu.be/SWua1y0ydh8
This video offers a closer look at the work of the Horizon Europe project METHYLOMIC. The video highlights the transformative potential of predictive biomarkers in the development of more effective and truly personalised treatments.
youtu.be/SMSQKP4C0Vg
#methylomic #IBD
On 10 December 2025, IFCCA, in collaboration with the Horizon Europe project METHYLOMIC, brought together leading experts, patient advocates, and people living with IBD to discuss how precision medicine is moving from theory to real benefit.
youtube.com/watch?v=3otRD_rpโฆ
The sixth newsletter about the METHYLOMIC project has been published. Read the latest news: methylomic.eu/wp-content/uplโฆ
#METHYLOMIC #targetinghope #EPIPSORA #OMICROHN #Crohns #RheumatoidArthritis
Vincent Joustra was awarded the 1st prize for the EPIC-CD study. This study aims to identify predictive biomarkers that can help personalize treatment strategies in Crohnโs disease by using blood-based DNA methylation signatures.
Read more: methylomic.eu/artikel/first-โฆ
#METHYLOMIC
Three questions for @tommasoparigi , clinician and researcher, San Raffaele Hospital and University about the METHYLOMIC Project.
Read his answers on our project website: methylomic.eu/artikel/three-โฆ
#METHYLOMIC #Crohns #research #IBD
In this podcast, journalist Shula Tas interviews Prof. Geert DโHaens about how methylation research aims to improve treatment selection for Crohnโs disease, Rheumatoid Arthritis and Psoriasis through personalized medicine.
Watch itย lnkd.in/eEJmm-si
#METHYLOMIC
In this episode, representatives of IFCCA share their views on the OmiCrohn clinical trial and reflect on the potential impact it may have on the lives of people living with Crohnโs disease.
methylomic.eu/artikel/podcasโฆ
#METHYLOMIC #OMICROHN #MethylomicMatters #CrohnsDisease
This podcast explores the Episora trial, a major study that uses AI to help determine which medication is most effective for each patient, offering a more efficient alternative to the current trial-and-error approach.
#METHYLOMIC #EPISORA #RheumatoidArthritis #AI #trial
Since the last update at the end of May, more participants have been enrolled in the OMICROHN study. And full study approval in Italy has been received.
#METHYLOMIC #Omicrohn #enrollment #update
This week, an article about the EPIC-CD Study was published in The Lancet Gastroenterology and Hepatology
Read and download the article on our website: methylomic.eu/artikel/resultโฆ
#METHYLOMIC #EPICcd #methylation #CrohnsDisease








